INDV
Indivior Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$34.88
−2.27%Forward multiples
Based on analyst estimates
- P/E forward
- 7.72x
- P/E 2026E
- 8.22x
- P/E 2027E
- 7.51x
- P/E 2028E
- 7.17x
- P/S forward
- 3.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.28x
- PEG TTM
- 0.21x
- Price / book
- -19.79x
- Price / sales
- 3.09x
- Price / cash flow
- -102.92x
Enterprise value
- Enterprise value
- $4.4B
- EV / sales
- 3.31x
- EV / EBITDA
- 10.19x
- EV / EBIT
- 8.50x
- Market cap
- $4.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026